Swangjit Suraamornkul

Decreased Plasma Adiponectin Concentrations Are Closely Related to Hepatic Fat Content and Hepatic Insulin Resistance in Pioglitazone-Treated Type 2 Diabetic Patients

Mandeep Bajaj, Swangjit Suraamornkul, Paul K. Piper et al. · The Journal of Clinical Endocrinology & Metabolism · 2004 · 356 citations

Pioglitazone Reduces Hepatic Fat Content and Augments Splanchnic Glucose Uptake in Patients With Type 2 Diabetes

Mandeep Bajaj, Swangjit Suraamornkul, Thongchai Pratipanawatr et al. · Diabetes · 2003 · 291 citations · Full text

Effect of a Sustained Reduction in Plasma Free Fatty Acid Concentration on Intramuscular Long-Chain Fatty Acyl-CoAs and Insulin Action in Type 2 Diabetic Patients

Mandeep Bajaj, Swangjit Suraamornkul, Anthony J. Romanelli et al. · Diabetes · 2005 · 178 citations · Full text

Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients

M Bajaj, Swangjit Suraamornkul, L. Jean Hardies et al. · International Journal of Obesity · 2004 · 161 citations

Insulin Resistance, Metabolic Syndrome, Obesity +12

Effects of peroxisome proliferator-activated receptor (PPAR)-α and PPAR-γ agonists on glucose and lipid metabolism in patients with type 2 diabetes mellitus

Mandeep Bajaj, Swangjit Suraamornkul, L. Jean Hardies et al. · Diabetologia · 2007 · 136 citations · Full text

Metabolic Syndrome, Diabetes Management, Medicine +11